Abstract:We have read with interest the comment of McDermott et al.1 on our article “Short pulse width widens the therapeutic window of subthalamic neurostimulation”.2 While the authors provide an elegant and sophisticated argument trying to prove our data wrong, they disregard a simple rule of experimentation from the viewpoint of theoretical biophysics: Deep brain stimulation systems do not have a “charge knob” to control the output of the neurostimulator. As correctly pointed out by McDermott et al., charge is the product of pulse duration and current. Both variables are controlled independently by the programmer and may be used to improve the selectivity of neurostimulation within a mixed nervous tissue containing target elements of deep brain stimulation (DBS) as well as side-effect elements. Our article describes from a clinical and experimental point of view, how to use the chronaxie relationship in clinical programming in order to avoid typical side effects of neurostimulation such as dysarthria or impaired fine motor skills by inadvertent stimulation of the pyramidal tract. In this experiment, the impact of a single variable (pulse duration) on the outcome variable current was assessed based on a threshold response. Their revised graph was simply showing the theoretical relationship between charge and pulse duration (which is trivial, because charge is the product of current amplitude and pulse duration as pointed out above), but was not experimentally assessed. We have a long experience in teaching novel programmers in adjusting the parameters of neurostimulation, which turns out to be a difficult task for clinicians, and had to perform multiple troubleshooting sessions ourselves in patients with poorly programmed DBS systems. The theoretical sophisticism of McDermott et al. adds confusion rather than providing a much needed practical guideline for DBS programming. We emphasize based on our experimental data and our clinical experience that DBS systems should be programmed treating pulse duration as a “constant” fixed at a low value (30–60 μsec depending on the hardware used) while using current or voltage for “dosing” the therapeutic response irrespective of any theoretical charge-pulse duration relationship.

Characterization of F-Actin Bundling Activity of Tetrahymena Elongation Factor 1&agr; Investigated with Rabbit Skeletal Muscle Actin

Thermal imaging bundle - A potential tool to enhance minimally invasive medical procedures

[Commentary] modern treatment for prisoners.

Biological Degradation of Aflatoxin B1 by Cell-Free Extracts of Bacillus velezensis DY3108 with Broad PH Stability and Excellent Thermostability

Biodegradation Characteristics and Mechanism of Aflatoxin B1 by Bacillus amyloliquefaciens from Enzymatic and Multiomics Perspectives

Screening and identification of an aflatoxin B1-degrading strain from the Qinghai-Tibet Plateau and biodegradation products analysis

Detoxification of Aflatoxin B1 by a Potential Probiotic Bacillus amyloliquefaciens WF2020

Degradation of Aflatoxin B1 by recombinant laccase extracellular produced from Escherichia coli

Identification of a Novel Aflatoxin B1-Degrading Strain, Bacillus halotolerans DDC-4, and Its Response Mechanisms to Aflatoxin B1

On the stabilization of A-15 Nb3Ge with high TC's

Isolation and Aflatoxin B1-degradation Characteristics of a Microbacterium proteolyticum B204 Strain from Bovine Faeces

Some differentials in infant and child mortality risks in Pakistan 1962 - 1986.

Degradation of aflatoxin B(1) by fungal laccase enzymes

Detoxification of aflatoxin B1 by a Bacillus subtilis spore coat protein through formation of the main metabolites AFQ1 and epi-AFQ1

[A technical breakthrough for understanding segmentation clock dynamics and synchrony].

Effective degradation of aflatoxin B1 using a novel thermophilic microbial consortium TADC7

Degradation and Detoxification of Aflatoxin B1 by Tea-Derived Aspergillus niger RAF106

Principles-Based Standards and Earnings Attributes

Recombinant Oxidase from Armillaria tabescens as a Potential Tool for Aflatoxin B1 Degradation in Contaminated Cereal Grain

Reply to comment on: Short pulse width widens the therapeutic window of subthalamic neurostimulation

Cloning of Three Aflatoxin B1 Oxidases of the Dipeptidyl Peptidase III Family and Evaluation of Their Potential for Practical Applications as Decontamination Enzymes